Tropoelastin is the dominant monomer that assembles to form elastin, which confers elasticity to vertebrate elastic tissues including skin, arteries, and lungs. Tropoelastin interacts with cells through cell surface receptors including integrins and glycosaminoglycans (GAGs). As the region 17-18 is recognized as a key region in cell attachment and spreading, we utilized C-terminal truncated tropoelastin constructs containing dissected sections of domain 18. We mapped a cell-interactive sequence of tropoelastin to domain 17 and the first six amino acids (aa) of domain 18. Further delineation identified a 21-residue sequence (Peptide 302-322) which promoted cell attachment and spreading indistinguishable from that to N18, a construct encompassing the full domains 17-18. Alanine substitution of the lysines at positions 11 and 14 in Peptide 302-322 effectively abolished cell binding. This reliance on lysines pointed to a role for GAGs, which was assessed by heparan sulfate inhibition, leading to 85.9 AE 4.2% decreased cell binding, while inhibition of integrins using ethylenediaminetetraacetic acid did not affect attachment. In contrast, selective antibody blocking of the integrin a v family prevented cell spreading by 92.5 AE 8.9%. We propose a two-step mechanism by which cell interactions occur at this central region of tropoelastin: initially, cell adhesion is mediated by GAGs, which contact the lysine residues within the target sequence, and subsequently facilitate cell spreading modulated by integrins, specifically a v b 3 and a v b 5 . We conclude that this region comprises a tropoelastin-derived, cell-interactive sequence that independently mediates potent cell binding and spreading via sequential recognition of GAG and integrin cell surface receptors.
Introduction
Elastic fibers are a key structural component of the extracellular matrix (ECM), where they confer elasticity on all vertebrate elastic tissues, including arteries, lung, skin, vocal fold, and elastic cartilage, which are subjected to repetitive extensile forces [1, 2] . Elastic fibers predominantly comprise elastin which is intermingled with fibrillin-rich microfibrils [1] . In addition to its role in elasticity, elastin influences the chemotaxis, attachment, spreading, proliferation, and differentiation of a range of cell types such as fibroblasts, smooth muscle cells, and endothelial cells [3] . Tropoelastin, the monomer form of elastin, is known to mediate these cellular processes, either via interactions with other ECM proteins such as fibulin-5 [4] , or through direct interactions with cell receptors including the elastin-binding protein (EBP) [5] , glycosaminoglycans (GAGs) [6] , and integrins [7] .
Cell receptor interactions with the ECM are crucial for cell survival and tissue maintenance [8] . EBP is a multifunctional peripheral membrane protein involved in the transport and cell signaling interactions of tropoelastin and is proposed to play a crucial role in preventing intracellular aggregation and proteolysis of tropoelastin [9] . It is also capable of recognizing short hydrophobic sequences, primarily VGVAPG, which is a recurring sequence in tropoelastin [5] . This peptide has been shown to promote the chemotaxis and proliferation of fibroblasts and monocytes, as well as angiogenesis and protease release [10] [11] [12] . EBP can also bind other elastin sequences which conform to the XGXXPG motif, such as PGIVPG [13] . Despite its role in cell signaling interactions with tropoelastin, EBP has been shown to be not responsible for cell adhesion, but rather acts a signal of elastin damage [14, 15] .
Glycosaminoglycans are linear, negatively charged, acidic polysaccharides that are linked to proteoglycans, including receptors of the syndecan family that reside on cell membranes [16] . Mainly the negative charges associated with GAGs facilitate their interaction with many ECM proteins and other cell receptors for cell-cell signaling and cell-matrix adhesion interactions [17] . As they are negatively charged, GAGs can interact with positively charged amino acids such as lysines in a number of molecules including tropoelastin [18] [19] [20] [21] [22] . Previous studies have proposed that cell-elastin adhesion involves cell surface GAG interactions with the C-terminal region of bovine tropoelastin [23] . In contrast, the use of a GAGcompetitive inhibitor such as heparan sulfate (HS) was not seen to inhibit cell binding to full-length human tropoelastin, suggesting the additional involvement of another receptor(s) in mediating cell interactions [7] .
Integrins influence cellular morphology, and facilitate processes such as cell migration and proliferation, wound repair, tissue organization, development, and host immune responses [24] [25] [26] . Integrins also participate in the pathogenesis of a wide range of diseases such as arthritis, cardiovascular disease, inflammation, microbial and parasitic infection, cancer, and glaucoma [27] [28] [29] [30] . Integrins are heterodimeric transmembrane receptors containing one a subunit and one b subunit [25] . In humans, 18 different a subunits and 8 different b subunits can dimerize to form a wide range of receptor combinations targeted toward specific ECM ligands.
A primary goal in the matrix biology field has been to reduce macromolecular ligands to minimal recognition sequences. The RGD sequence is perhaps the most recognized example of this in the integrin field. RGD was originally derived from fibronectin [31, 32] and has since been found in other ECM, blood, and cell surface proteins [33] . It was previously thought that integrins recognize only the RGD motif; however, it is now accepted that non-RGD motifs such as the GRO-GER and GFOGER sequences, derived from the major collagens [34, 35] , can also function as integrin ligands. Short sequences that bind GAG-containing syndecans have also been investigated, such as the positively charged RKRLQVQLSIRT sequence derived from the ECM molecule laminin [36] .
Fibronectin, collagen, and other well-researched molecules have been largely mapped for cell adhesion sites; however, there has not been a lot of studies on tropoelastin [37] . Cell attachment to tropoelastin is critical to elastic fiber assembly, as cells are important for organizing fibers into tissue-specific three-dimensional architectures [38, 39] . Cell spreading follows cell attachment, and involves the rapid rearrangement of actin stress fibers usually through integrins [40, 41] . These cellular processes are essential for cell growth, migration, and invasion [42, 43] . Downstream signaling effects triggered by cellular interactions with tropoelastin also contribute to the wound healing process [15] . Additionally, understanding the cell adhesive properties of tropoelastin and identifying the specific regions underlying this functionality are important for biomaterial design. For example, early domains of tropoelastin have been used to enhance the vascular compatibility of surfaces [44] . The region containing domains 17-18 in tropoelastin is recognized as significant to cell attachment and spreading [45] . In this current study, we dissect this region and identify a cell-binding sequence in this central region of tropoelastin. We also identify the specific amino acid residues and receptors involved in fibroblast binding and spreading.
Results
Recombinant human tropoelastin constructs with truncations in the domain 18 region support human dermal fibroblast attachment Using truncated tropoelastin constructs, we previously narrowed down a cell-binding site in tropoelastin to the central region containing domains 17 and 18 ( Fig. 1A) [45] . To continue studies on these specific domains, we utilized truncated versions of recombinant human tropoelastin which dissect the domain 17-18 region: N18 (aa 27-365), aa 27-346, aa 27-330, and aa 27-322 (Fig. 1A) . These tropoelastin constructs showed dose-dependent adhesion to fibroblasts (Fig. 1B) . At maximal 200 nM coating concentrations, there were no significant differences in cell adhesion between N18 (68.1 AE 7.3%) and aa 27-346 (61.8 AE 1.2%), between aa 27-346 (57.1 AE 2.9%) and aa 27-330 (53.6 AE 2.9%), and between aa 27-330 (53.6 AE 2.9%) and aa 27-322 (54 AE 1.1%) (Fig. 1B) . N18 and aa 27-322 at the maximal coating concentration also showed equivalent cell-binding (82.5 AE 5.4% and 77.3 AE 2.3%, respectively) properties (Fig. 1B) , indicating that a cell adhesive sequence lies fully within domain 17 and the first six residues of domain 18.
Peptide 302-322, a sequence corresponding to the central domain of tropoelastin, supports fibroblast adhesion and spreading
The tropoelastin construct aa 27-322, which lacks the majority of domain 18, was still able to support cell attachment. Peptide 302-322 was synthesized to span part of the domain 17-18 region of aa 27-322 (AAAAAAAAAAKAAKYGAAAGL) (Fig. 2A) . This region is distinctive because it contains the longest alanine and lysine stretch in tropoelastin. The sequence of Peptide 302-322 starts at the beginning of this alanine stretch. To control for nonspecific positive charge effects, we used a peptide containing the scrambled domain 36 sequence of tropoelastin (AKGLRCKG KARC), named negative peptide control ( Fig. 2A) . Domain 36 has previously been showed to adhere to cells [7] , but this interaction is sequence dependent, and as such, the scrambled version does not bind to cells (Fig. 2B) .
Peptide 302-322-coated wells showed dose-dependent adhesion to fibroblasts ( control peptide did not adhere to cells (2.4 AE 0.8%). N18 served as the positive control as Fig. 1 showed it was indistinguishable from the constructs aa 27-346, aa 27-330, and aa 27-322 at the maximal coating concentration (200 nM). These results support the presence of a site within the overlapping region in tropoelastin constructs aa 27-322 and 17-27 that is responsible for fibroblast adhesion. Phase-contrast microscopy was used to visualize the spreading of fibroblasts after 60 min on Peptide 302-322 in comparison to N18 (Fig. 2C ). Peptide 302-322 supported cell spreading (58.6 AE 10.8%) at levels not significantly different to N18 (71.5 AE 9.5%). Representative images (Fig. 2D) showed that the majority of cells on N18 and Peptide 302-322 were phase-dark, had cellular projections, and displayed a flattened morphology consistent with spread fibroblasts.
We tested the inhibitory effect of this peptide on cell spreading onto tropoelastin constructs N18 and 17-27 ( Fig. 3) . Peptide 302-322 at 60 lM significantly inhibited cell spreading on both N18 (19.1 AE 9.4%) with a P-value of P < 0.0001 ( Fig. 3A ) and 17-27 (0.6 AE 1.1%) with a P-value of P < 0.001 (Fig. 3B ), in contrast to the no-peptide control (72.7 AE 6.5% and 39 AE 5.6%) and the negative control peptide (72.7 AE 9.3% and 26 AE 8.3%).
On this basis, the sequence that corresponds to a portion of tropoelastin domains 17 and 18 is sufficient to promote cell attachment and spreading at a comparable extent to the N18 tropoelastin construct. Although Peptide 302-322 is shown to be a dominant cell-binding region in tropoelastin, we do not discount the possibility of other binding sites within the constructs N18 and 17-27.
Lysines are crucial for tropoelastin-fibroblast interactions
To identify amino acids in Peptide 302-322 responsible for integrin interactions, mutant peptides were constructed in which the tyrosine or either lysine in Peptide 302-322 was replaced with an alanine (Peptide 302-322 (Y->A): AAAAAAAAAAKAAKAGAAAGL; Peptide 302-322 (K1->A), AAAAAAAAAAKAAAY GAAAGL; and Peptide 302-322 (K2->A): AAAAA AAAAAAAAKYGAAAGL) (Fig. 4A) .
Peptide 302-322 (Y->A) showed dose-dependent adhesion to fibroblasts (Fig. 4Bi) In contrast, Peptide 302-322 (K1->A) and Peptide 302-322 (K2->A), in which each lysine was substituted with an alanine, substantially reduced cell binding by 71.9 AE 5.9% and 66.9 AE 7.3%, respectively (Fig. 4Bii ). This marked difference indicated the critical role of both lysines in adhering to cells. Because a substantial knock down to baseline levels of cell adhesion was seen with one lysine substitution, there was no need to further explore the substitution of both lysines.
Consistent with their relative cell-binding capabilities, Peptide 302-322 (Y->A) supported fibroblast spreading (66.9 AE 20.6%) similar to Peptide 302-322 (67.4 AE 23.4%), while Peptide 302-322 (K1->A) and Peptide 302-322 (K2->A) led to negligible levels of cell spreading (0.4 AE 0.8% and 2 AE 1.8%). These corresponded to inhibition of 98.9 AE 2.3% and 97.3 AE 2.6% for each mutant form (Fig. 5A ). Representative phase-contrast microscopy images showed that the majority of cells on Peptide 302-322 (K1->A) and Peptide 302-322 (K2->A) were rounded and phase-bright (Fig. 5B) . In contrast, cells on Peptide 302-322 and Peptide 302-322 (Y->A) were phase-dark and had cellular projections accompanied by a flattened cell morphology. The marked functional difference in modified forms of Peptide 302-322 with lysine substitutions indicates that these residues are crucial for tropoelastin-cell interactions. In contrast, the tyrosine residue did not appear to have a direct role in mediating this interaction and may instead have a regulatory role in this process.
Peptide 302-322 adhesion to fibroblasts is mediated by heparan sulfate and independent of integrins
The decrease in efficacy as the result of sequential lysine substitutions was consistent with a model of interactions with cell surface GAGs. Given the proposed involvement of HS in other studies with tropoelastin, HS was examined as a competitor in this study [6] . In the presence of HS (Fig. 6A) , cell binding to Peptide 302-322 was substantially reduced by 85.9 AE 4.2%. In contrast, HS did not affect the binding of cells to tropoelastin constructs aa 27-322, N18, and 17-27 which indicates that isolating the Peptide 302-322 sequence from the longer tropoelastin constructs exposed a GAG-binding site.
We had previously identified that integrins are involved in tropoelastin-cell interactions. Here, we investigated the involvement of integrins in cell interactions with Peptide 302-322. We examined the effect of ethylenediaminetetraacetic acid (EDTA) on cell binding to Peptide 302-322 and aa 27-322, using N18 and 17-27 as positive controls. The inclusion of 5 mM EDTA did not diminish the binding of fibroblasts to Peptide 302-322, but significantly reduced cell adhesion to aa 27-322, N18, and 17-27 (Fig. 6B) . The slight decrease in cell attachment to Peptide 302-322 may be due to the length of exposure to EDTA during incubation time. To confirm this lack of cation dependence, concentration gradients of Ca 2+ , Mg 2+ , and Mn 2+ were added to fibroblasts in cation-free buffer (Fig. 6C,D) . Consistent with the EDTA inhibition data, cell attachment to Peptide 302-322 (Fig. 6C) did not show characteristic cation dependency, unlike that to N18 (Fig. 6D) . In this case, maximal cell attachment was restored with concentrations of up to 0.4 mM Mn 2+ , followed by Mg 2+ , which also stimulated cell attachment but to lower levels, and Ca
2+
, which stimulated the lowest levels of cell attachment. This cation dependency has been used to identify integrin involvement in cell-protein interactions [46] .
These data are consistent with a model where the sequence in the central region of tropoelastin corresponding to Peptide 302-322 adheres to cells via a GAG-mediated mechanism independent of integrins. However, as this contrasts with the mechanism of cell attachment to the longer and adjacent N18 and 17-27 sequences, we propose that integrins mediate cell binding to regions outside domains 17-18. Peptide 302-322 interacts with a v -containing integrins on fibroblasts for cell spreading on tropoelastin
To further explore the role of integrins in relation to Peptide 302-322 at this stage, a cell attachment study incorporating anti-integrin antibodies was conducted with Peptide 302-322. Inclusion of the 17E6 pan antia v integrin inhibitory antibody, the P1F6 anti-a v b 5 integrin antibody, the VNR1 anti-a v b 3 integrin antibody, and the negative control antibody against integrin b 8 did not significantly inhibit cell attachment to Peptide 302-322 (Fig. 7A) . We also investigated the role of integrins in cell spreading on Peptide 302-322. Inclusion of the 17E6 pan anti-a v integrin antibody significantly inhibited cell spreading on Peptide 302-322 by 92.5 AE 8.9% (Fig. 7B) . This inhibition by 17E6 can be explained by the need for an a v -containing integrin for cell spreading on Peptide 302-322. A negative antibody control, which was directed against the integrin b 8 , did not inhibit cell spreading on Peptide 302-322. P1F6, an anti-a v b 5 integrin antibody, and VNR1, an anti-a v b 3 antibody, were included to determine the contributions of the b 5 and b 3 subunits. These antibodies inhibited cell spreading onto Peptide 302-322 by 35.9 AE 17% and 31.7 AE 7.1%, respectively (Fig. 7C) . To control for the specificity of the P1F6 antibody, collagen type 1, which is not a ligand of the integrin a v b 5 , was included in the assay. Cell spreading on collagen type 1 was not inhibited by P1F6 (Fig. 7D) . These data indicate that the a v -containing integrins a v b 3 interact with Peptide 302-322 for cell spreading, and suggest that integrin interactions here do not drive cell attachment, and are confined to spreading in this part of the tropoelastin molecule.
Discussion
Cells adhere and spread on ECM proteins through a wide variety of cell surface mechanisms. These processes are vital for cell survival and tissue maintenance. Short sequences that have been derived from various ECM proteins such a fibronectin and laminin promote these processes. However, there is less knowledge of the corresponding role of sequences derived from tropoelastin. Studies have shown that GAGs interact with the C-terminal region of bovine tropoelastin [23] , but GAG interactions with human tropoelastin are less explored [47] . Through inhibition studies that block universal alpha v or specific alpha v and beta 3/5 subunit function, we have previously demonstrated that integrins, specifically a v b 3 and a v b 5 , interact with tropoelastin [7, 45] . In particular, integrin a v b 5 has been shown to recognize a sequence within the tropoelastin constructs N18 and 17-27 [7, 45] .
We previously proposed a cell-interactive site located in the central domain 17-18 region of the molecule [45] . In this study, we made a series of tropoelastin constructs that contain varying lengths of the domain 18 sequence (Fig. 1A) . These constructs showed cell attachment comparable to the N18 construct containing the full domain 18 sequence. On this basis, we derived Peptide 302-322, which corresponds to the AAAAAAAAAAKAAKYGAAAGL sequence within the shortest aa 27-322 construct ( Fig. 2A) , and used it to map the cell-binding site in this central region. We discovered that cell surface GAG and integrin receptors recognize this sequence independently from the rest of tropoelastin, and that the peptide mediates both cell attachment and spreading. This sequence represents a novel cell-interactive motif derived from tropoelastin that recognizes both GAG and integrin receptors.
There are advantages in isolating a peptide to target specific cell adhesion receptors, as the full-length protein can contain several sequences that are recognized by distinct cell surface receptors or different types of the same receptor family [37, 48] . These sequences can have widely varied effects on downstream signaling. For example, GAGs induce signaling pathways that differ from integrins and so can initiate different cellular processes [49] . Even different families of integrins exhibit different effects, for example GFOGER, a sequence derived from collagen which binds to integrins a 1 b 1 and a 2 b 1 [35] , induces different signaling processes to the LDV motif derived from fibronectin, which binds to integrin a 4 b 1 [37] . In addition, the ligands cRGD and cHarGD, which bind to distinct sites on the same aIIIbB3 receptor, initiate different functional consequences within the receptor [50] . Therefore, discovering novel and specific cell-binding sequences through multiple receptors opens possibilities for fine tuning the regulation of cellular responses. Our study identifies a sequence in the tropoelastin molecule that independently binds cells and allows cell spreading, each of which are vital processes in cell migration and wound healing [51] [52] [53] . Previous studies have proposed indirect cell binding to tropoelastin involving the bridging protein fibulin-5 [4, 54] . Our assays do not exclude this additional pathway, and are of a short time frame where cells are seeded on peptide coated wells for 1 hr, reducing the availability of cell-secreted proteins and so excluding their meaningful function as bridging molecules between tropoelastin and cellular receptors. Our methods also include a blocking step, which prevents newly synthesized protein from potentially binding to substrata and thus to cells. Therefore, these studies show a direct interaction between a peptide corresponding to a centrally located tropoelastin sequence and receptors on the surface of cells.
Mutations were introduced into Peptide 302-322 to investigate the specific amino acids involved in mediating cellular interactions. Features of these perturbing tyrosine and lysines in our tropoelastin-derived sequence are variously present in multiple ECM-binding ligands, such as the laminin-derived YIGSR and DYATLQLQEGRLHFMFDLG sequences [55] [56] [57] , the GRKRK motif in tropoelastin, and the RKKH sequence derived from jararhagin, a hemorrahagic snake venom metalloproteinase. Therefore, these residues in Peptide 302-322 were sequentially alanine-substituted to investigate their role in cell interactions (Fig. 4A) . Replacing the tyrosine did not reduce cell attachment, whereas replacing any of the lysines profoundly inhibited the peptide's ability to support cell binding then spreading. We conclude that lysines are crucial in cell-Peptide 302-322 interactions. The negatively charged GAG molecules are known to interact with positively charged lysine residues in tropoelastin during various stages of elastin assembly [22, 58] . At physiological pH, the lysine residues are expected to be protonated, which allows electrostatic interactions with the negatively charged GAGs [22] .
Likewise, GAGs have been shown to bind a range of other molecules through their lysine residues [18] [19] [20] [21] . Cell surface heparin and chondroitin sulfate which contain GAGs have been reported to mediate interactions between chondrocytes and bovine tropoelastin [6] . However, GAG-mediated cell interaction has not yet been shown with human tropoelastin. The lack of cell interactions with the negative control peptide, which contains three lysine residues, supports a model where the Peptide 302-322-GAG interactions are sequence-dependent, and indeed that an increased positively charged content does not necessarily dictate higher levels of cell attachment.
Cell spreading follows cell attachment. Monoclonal antibody inhibition studies identified a v integrin involvement in fibroblast spreading on Peptide 302-322. However, integrins do not appear to be the main receptors for cell attachment. This was supported by the lack of cation dependence in the cell attachment process. Integrins a v b 3 and a v b 5 have previously been shown to interact with tropoelastin [7, 45] . In this study, the inclusion of both P1F6 and VNR1 antibodies inhibited cell spreading on Peptide 302-322, confirming the involvement of both a v b 3 and a v b 5 integrins in this process. The utilization of these integrins during cell-tropoelastin interactions is consistent with integrin a v b 5 and a v b 3 expression by fibroblasts [59] [60] [61] , where they also mediate cell adhesion to other ECM proteins including vitronectin, fibrinogen, and fibronectin [62] . Our results point to the possibility that strong adhesion through integrins may be in one or more separate regions outside of domains 17-18. We propose that fibroblast attachment and spreading on Peptide 302-322 occurs in two steps: (a) cell surface GAGs initially bind to the peptide, which then (b) induces local enrichment of the integrin a v family and promotes cell spreading. This type of stepwise mechanism has been observed in other studies, where heparin inhibits fibroblast attachment, while anti-integrin a 2 or b 1 antibodies inhibit fibroblast spreading on the laminin a1 chain LG4 module [63] . Furthermore, two active peptides derived from the mouse laminin a1 chain, AG73 which binds to syndecan, and EF1 which interacts with a 2 b 1 integrin, demonstrate different levels of cell binding and spreading. The AG73 peptide promotes only cell attachment, whereas the EF1 peptide promotes both cell attachment and spreading, supporting the notion that syndecans are responsible for the cell attachment process, while integrins are vital for cell spreading [36, 64] . Similarly, the ADAM12 metallopeptidase sequence contains a cysteine-rich domain that initially binds mesenchymal cell syndecans, which in turn promote cell spreading through integrin b 1 [65] . This role for syndecans in initiating the integrin function is well-documented [66] [67] [68] [69] For example, integrin a v b 3 signaling during cell spreading on vitronectin is dependent on the activation of syndecan-1 [69] . Similarly, the assembly of syndecan-1 into a cell surface complex regulates a v b 5 integrin signaling in fibroblasts [70] . Integrin a 5 b 1 signaling has also been shown to rely on the initial accumulation of syndecan-2 during carcinoma cell attachment to fibronectin [66] . A similar cooperation between GAG-containing syndecans and integrins may be required for full attachment and spreading of cells on the Peptide 302-322 sequence. Cell anchorage by syndecans to the protein ligand potentially facilitates subsequent integrin engagement, which is consistent with the relative maximum reach distance of each receptor (Fig. 8A) [67] . The HS chains of syndecans have a potential reach of 500 nm [71] in contrast to the shorter reach of integrins at 17 nm [68] . Syndecan-2 and syndecan-3 have been suggested as probable candidates for interactions with tropoelastin due to a predominance of filopodial extensions in tropoelastin-adherent cells, resembling the effects of the overexpression of these receptors [6, 72] . ECM interactions with integrins are known to trigger intracellular pathways to promote actin cytoskeletal assembly [73] ; indeed, we have shown that adhesion and spreading on tropoelastin involves actin polymerization [45] . Other cell types such as human umbilical vein endothelial cells [44] and smooth muscle cells (T. Bartolec & A. S. Weiss, unpublished data) have been shown to adhere and spread to tropoelastin constructs. We hypothesize that these interactions involve a similar two-step mechanism involving GAG and integrin interactions. However, we do not discount the concept that different populations of cell receptors could elicit cell binding and spreading.
Through these studies, we identified a GAG-binding site in the central region of tropoelastin (Fig. 8B) . Furthermore, this site works synergistically with integrins: GAGs initially bind to the peptide, which then allows engagement of the integrin a v family to induce cell spreading. The addition of HS GAGs has been shown to alter the deposition of tropoelastin into the ECM [74, 75] . Additionally, in vitro studies using HS have been shown to alter the coacervation properties of tropoelastin and induce the aggregation of tropoelastin into an ordered fibrillar structure, confirming the importance of GAGs in elastic fiber assembly [22, 76] . Interestingly, it has been shown that the incorporation of lysine into integrin-adhesive peptides improves the cell adhesion performance of biomaterials [77] . Additionally, a mixture of integrin and GAG-binding peptides promotes stronger cell attachment and spreading than the individual peptides, commensurate with the advantages of a synergistic function for GAGs and integrins [36] .
By distilling the cell-binding site to a short Peptide 302-322 sequence, this work has opened opportunities for fine tuning the regulation of cellular responses. Although extensive alternative splicing is a characteristic of elastin mRNA, domain 17 of tropoelastin has not been observed to be subjected to alternative splicing, which is consistent with its role in elastin function [78, 79] . Additionally, domain 17 is one of the few lysine-rich regions in tropoelastin that does not participate in cross-linking [80, 81] , leaving the lysine residues available for cell receptor interactions. Domains 16-17 are important in tropoelastin selfassembly and elastic fiber formation [82] , where the cell-interactive ability of tropoelastin has been shown to be associated with elastic fiber assembly [83] . Here, we find that part of the hydrophilic domain 17 interacts with cells. This short sequence allows for cell adhesion through GAGs, which then in turn facilitate integrin-mediated cell spreading. As the tropoelastin construct aa 27-322 still shows a significant level of cell binding with the addition of HS as an inhibitor, we hypothesize that the dominant integrin-binding sites are in exposed regions outside domains 17-18 ( Fig. 8B) [45] . The sequence composition of domain 17 resembles that seen in other tropoelastin domains such as domains 15 
Tropoelastin construct expression
Tropoelastin constructs encoding the N terminus to domain 18 (N18; aa 27-365), domains 17-27 (17-27; aa 297-595), and constructs that contain carefully dissected sections of domain 18, aa 27-346, aa 27-330, and aa 27-322 were cloned in-house into the pET3d vector from the WT fulllength tropoelastin sequence corresponding to amino acid residues 27-724, Database ID: AAC98394 (gi 182020). The constructs were transformed into Escherichia coli BL21 (DE3) cells and overexpressed as described [84] . The protein was isolated as previously described [84] and then further purified by reversed phase high-performance liquid chromatography using an Agilent Technologies (Santa Clara, CA, USA) ZORBAX StableBond 300SB-C18 5 lm column. A gradient of 0-100% acetonitrile and 0.1% trifluoroacetic acid over 1 h was used to elute protein fractions. The purified tropoelastin constructs were dissolved in phosphate-buffered saline (PBS) for subsequent studies. Sodium dodecyl sulfate polyacrylamide gel electrophoresis confirmed single discrete species corresponding to predicted molecular masses.
Cell culture
GM3348 human dermal fibroblasts were cultured in Dulbecco's modified eagle's medium supplemented with 10% (v/v) fetal bovine serum and passaged 1 : 3 every 3-4 days.
Cell attachment and spreading
Cell attachment and spreading analyses were performed as described previously [7] . For both the attachment and spreading assays, cell suspensions were added onto tropoelastin-coated and denatured bovine serum albumin-blocked wells and were incubated for 1 h at 37°C. For attachment analyses, the wells were washed three times with PBS to remove loosely adherent cells before fixing the adherent cells in 3% (v/v) formaldehyde. Adherent cells were stained with 0.1% (w/v) crystal violet in 0.2 M 2-(N-morpholino) ethanesulfonic acid (pH 5.0) for 1 h. For cell spreading, cells were not aspirated and were instead fixed directly to the culture wells with 3% (v/v) formaldehyde. A cell suspension of 2.5 9 10 5 cellsÁmL À1 was used for all attachment analyses, and a cell suspension of 1 9 10 5 cellsÁmL
À1
was used for all spreading analyses. For cell spreading assays, cells were visualized by phase-contrast microscopy with a Zeiss Axiovert.A1 microscope (Carl Zeiss AG, Oberkochen, Germany) at 109 magnification, and images were taken on a microscope camera (AxioCam IC 1, Carl Zeiss AG) for cell spreading quantification. The degree of cell spreading was measured using a yes/no threshold methodology. Cells with a flattened phase-dark body and visible nucleus were considered spread, whereas cells that were rounded and phase-bright were considered unspread.
Inhibition studies
Inhibition studies were conducted following cell attachment or spreading assay protocols as described above. 
Statistical analyses
Experiments were carried out in triplicate or quadruplicate as indicated and reported as mean AE standard deviation of mean (SD). One-way or two-way analysis of variance applied with Bonferroni's post-tests was used. Data were accepted as statistically significant at P < 0.05 (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).
